Please login to the form below

Not currently logged in

ABPI names first project director for manufacturing

James Christie joins from Oxford BioMedica

James Christie, ABPIThe Association of the British Pharmaceutical Industry (ABPI) has named James Christie as its first project director with responsibility for manufacturing.

Christie's primary focus will head the implementation of work under the Medicines Manufacturing Industry Partnership (MMIP) as approved recently by the Ministerial Industry Strategy Group.

ABPI and the BioIndustry Association (BIA) established the MMIP in September this year to create a suitable environment for medicines manufacturing.

Commenting on his appointment, Christie said: “I am delighted to join the ABPI at what is a really exciting time considering the recent establishment of the MMIP. I am looking forward to leading an ambitious joint work programme on manufacturing technology, innovation, skills and regulation.”

Prior to joining ABPI, Christie worked for Oxford BioMedica as head of manufacturing and supply chain for over three years. He has also held senior management positions as GSK, Celltech Group and Centocor BV.

ABPI chief executive Stephen Whitehead said: “I believe that James will enable the MMIP to work towards creating an attractive and innovation-driven environment to ensure UK competitiveness in medicines manufacturing. This new role is an investment which will enable us to boost our leadership capability in this area.”

5th December 2014

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Brandcast Health

Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...